Difference between revisions of "Canine Adenovirus 2"
Jump to navigation
Jump to search
| Line 34: | Line 34: | ||
*Can be associated with [[Canine Infectious Tracheobronchitis|kennel cough]] described above | *Can be associated with [[Canine Infectious Tracheobronchitis|kennel cough]] described above | ||
| − | [[Category:Adenoviridae]][[Category:Dog Viruses]][[Respiratory Pathology - Dog]] | + | [[Category:Adenoviridae]][[Category:Dog Viruses]][[Category:Respiratory Pathology - Dog]] |
[[Category:To_Do_-_Clinical/Viruses]] | [[Category:To_Do_-_Clinical/Viruses]] | ||
[[Category:Respiratory_Viral_Infections]] | [[Category:Respiratory_Viral_Infections]] | ||
Revision as of 16:27, 14 December 2010
 |
This article is still under construction. |
Also known as: Infectious Canine Laryngotracheitis
Antigenicity
- Some antigenicity shared between CAV 1 and 2, which lends to vaccination
Pathogenesis
- Causes necrosis of the respiratory tract with NO concurrent hepatitis
- Animals present with:
- Pyrexia
- Mild depression
- Nasal/ocular discharges
- Corneal opacity (not always)
- Dry, harsh, persistent cough
Epidemiology
- Transfer is same as for CAV 1
Diagnosis
- Virus isolation from respiratory secretions
Control
- Isolate coughing dogs and disinfect premises
- Vaccination: CAV 1 vaccine will cross protect
- Adenoviridae
- Usually mild bronchointerstitial pneumonia, necrosis of bronchiolar and alveolar epithelium, oedema, type II pneumocyte hyperplasia
- May cause necrotising bronchiolitis in immune-deficient dogs (distemper)
- Can be associated with kennel cough described above